Skip to main content

30.04.2024 | Inflammatory Disorders

Peripheral CD3+CD4+ T cells as indicators of disease activity in thyroid eye disease: age-dependent significance

verfasst von: Haiyang Zhang, Lianfei Fang, Yumeng Cheng, Yuhang Peng, Hui Wang, Mengda Jiang, Ling Zhu, Yinwei Li, Sijie Fang, Huifang Zhou, Jing Sun, Xuefei Song

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To provide an in-depth analysis of the association of peripheral lymphocytes and the disease activity of thyroid eye disease (TED).

Methods

This retrospective study enrolled 65 active TED patients and 46 inactive TED patients. Comparative analyses of peripheral lymphocyte subsets were conducted between active and inactive patients. Subgroup analyses were performed based on sex, age, disease duration, and severity. Correlation analyses explored the associations between lymphocyte subsets and TED activity indicators. Prediction models for TED activity were established using objective indicators.

Results

Significantly elevated levels of CD3+CD4+ T cells were observed in active TED patients compared to inactive patients (P = 0.010). Subgroup analyses further revealed that this disparity was most prominent in females (P = 0.036), patients aged 50 years and younger (P = 0.003), those with long-term disease duration (P = 0.022), and individuals with moderate-to-severe disease (P = 0.021), with age exerting the most substantial impact. Subsequent correlation analysis confirmed the positive association between CD3+CD4+ T cells and the magnetic resonance imaging indicator of TED activity among patients aged 50 years and younger (P = 0.038). The combined prediction models for TED activity, established using objective indicators including CD3+CD4+ T cells, yielded areas under curve of 0.786 for all patients and 0.816 for patients aged 50 years and younger.

Conclusions

Peripheral CD3+CD4+ T cells are associated with disease activity of TED, especially in patients aged 50 years and younger. Our study has deepened the understanding of the peripheral T cell profiles in TED patients.
Literatur
7.
Zurück zum Zitat Bartalena L, Baldeschi L, Dickinson A, Eckstein A, Kendall-Taylor P, Marcocci C, Mourits M, Perros P, Boboridis K, Boschi A, Currò N, Daumerie C, Kahaly GJ, Krassas GE, Lane CM, Lazarus JH, Marinò M, Nardi M, Neoh C, Orgiazzi J, Pearce S, Pinchera A, Pitz S, Salvi M, Sivelli P, Stahl M, von Arx G, Wiersinga WM (2008) Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 158:273–285. https://doi.org/10.1530/eje-07-0666CrossRefPubMed Bartalena L, Baldeschi L, Dickinson A, Eckstein A, Kendall-Taylor P, Marcocci C, Mourits M, Perros P, Boboridis K, Boschi A, Currò N, Daumerie C, Kahaly GJ, Krassas GE, Lane CM, Lazarus JH, Marinò M, Nardi M, Neoh C, Orgiazzi J, Pearce S, Pinchera A, Pitz S, Salvi M, Sivelli P, Stahl M, von Arx G, Wiersinga WM (2008) Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 158:273–285. https://​doi.​org/​10.​1530/​eje-07-0666CrossRefPubMed
12.
Zurück zum Zitat Li H, Wang B, Li Q, Li Q, Qiao J, Lin D, Sui C, Ye L, Zhai H, Jiang B, Wang N, Han B, Jiang M, Tao X, Shao Z, Zhu C, Ma Y, Xiong P, Sun J, Zhou H, Lu Y (2023) T cell subsets are associated with clinical activity and efficacy of 4.5g intravenous glucocorticoid for moderate-to-severe thyroid-associated ophthalmopathy. Endocr Res 48:55–67. https://doi.org/10.1080/07435800.2023.2219734CrossRefPubMed Li H, Wang B, Li Q, Li Q, Qiao J, Lin D, Sui C, Ye L, Zhai H, Jiang B, Wang N, Han B, Jiang M, Tao X, Shao Z, Zhu C, Ma Y, Xiong P, Sun J, Zhou H, Lu Y (2023) T cell subsets are associated with clinical activity and efficacy of 4.5g intravenous glucocorticoid for moderate-to-severe thyroid-associated ophthalmopathy. Endocr Res 48:55–67. https://​doi.​org/​10.​1080/​07435800.​2023.​2219734CrossRefPubMed
14.
Zurück zum Zitat Hwang CJ, Afifiyan N, Sand D, Naik V, Said J, Pollock SJ, Chen B, Phipps RP, Goldberg RA, Smith TJ, Douglas RS (2009) Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1. Invest Ophthalmol Vis Sci 50:2262–2268. https://doi.org/10.1167/iovs.08-2328CrossRefPubMed Hwang CJ, Afifiyan N, Sand D, Naik V, Said J, Pollock SJ, Chen B, Phipps RP, Goldberg RA, Smith TJ, Douglas RS (2009) Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1. Invest Ophthalmol Vis Sci 50:2262–2268. https://​doi.​org/​10.​1167/​iovs.​08-2328CrossRefPubMed
16.
17.
23.
Zurück zum Zitat Bartalena L, Kahaly GJ, Baldeschi L, Dayan CM, Eckstein A, Marcocci C, Marinò M, Vaidya B, Wiersinga WM (2021) The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy. Eur J Endocrinol 185:G43–G67. https://doi.org/10.1530/EJE-21-0479CrossRefPubMed Bartalena L, Kahaly GJ, Baldeschi L, Dayan CM, Eckstein A, Marcocci C, Marinò M, Vaidya B, Wiersinga WM (2021) The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy. Eur J Endocrinol 185:G43–G67. https://​doi.​org/​10.​1530/​EJE-21-0479CrossRefPubMed
27.
Zurück zum Zitat Chen L, Hu H, Chen HH, Chen W, Wu Q, Wu FY, Xu XQ (2021) Usefulness of two-point Dixon T2-weighted imaging in thyroid-associated ophthalmopathy: comparison with conventional fat saturation imaging in fat suppression quality and staging performance. Br J Radiol 94:20200884. https://doi.org/10.1259/bjr.20200884CrossRefPubMed Chen L, Hu H, Chen HH, Chen W, Wu Q, Wu FY, Xu XQ (2021) Usefulness of two-point Dixon T2-weighted imaging in thyroid-associated ophthalmopathy: comparison with conventional fat saturation imaging in fat suppression quality and staging performance. Br J Radiol 94:20200884. https://​doi.​org/​10.​1259/​bjr.​20200884CrossRefPubMed
29.
Zurück zum Zitat Han R, Smith TJ (2006) T helper type 1 and type 2 cytokines exert divergent influence on the induction of prostaglandin E2 and hyaluronan synthesis by interleukin-1beta in orbital fibroblasts: implications for the pathogenesis of thyroid-associated ophthalmopathy. Endocrinology 147:13–19CrossRefPubMed Han R, Smith TJ (2006) T helper type 1 and type 2 cytokines exert divergent influence on the induction of prostaglandin E2 and hyaluronan synthesis by interleukin-1beta in orbital fibroblasts: implications for the pathogenesis of thyroid-associated ophthalmopathy. Endocrinology 147:13–19CrossRefPubMed
32.
Zurück zum Zitat Markle JGM, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, von Bergen M, McCoy KD, Macpherson AJ, Danska JS (2013) Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339:1084–1088. https://doi.org/10.1126/science.1233521 Markle JGM, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, von Bergen M, McCoy KD, Macpherson AJ, Danska JS (2013) Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339:1084–1088. https://​doi.​org/​10.​1126/​science.​1233521
37.
Zurück zum Zitat Su Y, Liu X, Fang S, Huang Y, Li Y, Zhong S, Wang Y, Zhang S, Zhou H, Sun J, Fan X (2022) Age-related difference in extraocular muscles and its relation to clinical manifestations in an ethnically homogenous group of patients with Graves’ orbitopathy. Graefes Arch Clin Exp Ophthalmol 260:583–589. https://doi.org/10.1007/s00417-021-05377-9CrossRefPubMed Su Y, Liu X, Fang S, Huang Y, Li Y, Zhong S, Wang Y, Zhang S, Zhou H, Sun J, Fan X (2022) Age-related difference in extraocular muscles and its relation to clinical manifestations in an ethnically homogenous group of patients with Graves’ orbitopathy. Graefes Arch Clin Exp Ophthalmol 260:583–589. https://​doi.​org/​10.​1007/​s00417-021-05377-9CrossRefPubMed
Metadaten
Titel
Peripheral CD3+CD4+ T cells as indicators of disease activity in thyroid eye disease: age-dependent significance
verfasst von
Haiyang Zhang
Lianfei Fang
Yumeng Cheng
Yuhang Peng
Hui Wang
Mengda Jiang
Ling Zhu
Yinwei Li
Sijie Fang
Huifang Zhou
Jing Sun
Xuefei Song
Publikationsdatum
30.04.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-024-06496-9

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.